An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.
Some professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Material Removal
According to the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at residence.
After moments of entering one community, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Item Details and Costs
Inside these groups, posts show black plastic parcels with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.
